SEC Form 4 · accession 0001209191-15-074560
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lynch
Director
Period of report
Oct 5, 2015
Accepted (ET)
Oct 7, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2015 | M | 3,000 | $2.0864 | A | 3,000 | D | |
| Common StockF2 | Oct 5, 2015 | S | 2,400 | $100.2302 | D | 600 | D | |
| Common StockF3 | Oct 5, 2015 | S | 600 | $101.15 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $2.0864 | Oct 5, 2015 | M | 3,000 | D | — | Jul 13, 2021 | Common Stock | 3,000 | 24,508 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2015.
- F2The range of prices for the transaction reported on this line was $100.00 to $100.64. The average weighted price was $100.2302. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $101.07 to $101.19. The average weighted price was $101.15. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011